Wegovy Tablets

Price range: £123.99 through £189.99

Wegovy (semaglutide) is a daily prescription weight loss tablet that helps adults with obesity or who are overweight achieve and maintain long-term weight management when combined with a healthy diet and regular exercise.

Note: The product supplied may vary to the image displayed. The image shown has been used for illustrative purposes only.
⊕ This medication may require an online consultation with a UK-registered prescriber to assess its suitability before a prescription can be issued.
Start Consultation

Wegovy (semaglutide) is a daily prescription weight loss tablet clinically proven to help adults with obesity or who are overweight achieve and maintain significant weight reduction.

It a GLP-1 receptor agonist.

This means Wegovy tablets mimic the effects of the GLP-1 hormone. This heps to regulate appetite, slow digestion, and reduce calorie intake, supporting long-term weight management when combined with a reduced-calorie diet and regular physical activity.

How Wegovy Works

Wegovy contains semaglutide, which mimics the natural hormone GLP-1 (glucagon-like peptide-1). This hormone plays a key role in controlling appetite and food intake.

By enhancing satiety signals, Wegovy helps you feel fuller for longer, reduces hunger cravings, and promotes healthier eating habits.

Why Choose Wegovy Tablets?

Wegovy offers multiple benefits for those seeking an effective medical weight management solution:

  • Proven Weight Loss Results: Clinical trials show that patients using Wegovy alongside lifestyle changes achieve significant, sustained weight loss.

  • Convenient Daily Dosing: No injections, to storage issues. Simply a pill taken each morning.

  • Gradual Dose Escalation: Treatment begins with a lower dose and is gradually increased to improve tolerability and reduce common side effects like nausea.

  • Broad Health Benefits: Weight loss with Wegovy can also lead to improvements in blood sugar control, cholesterol levels, and blood pressure, reducing the risk of obesity-related health conditions.

Who Can Use Wegovy?

Wegovy is suitable for:

  • Adults with a BMI of 30 or higher (classified as obesity).

  • Adults with a BMI of 27 or higher who also have at least one weight-related condition (e.g., type 2 diabetes, high blood pressure, or high cholesterol).

Not recommended for use with other prescription or over-the-counter weight loss products.

Important Safety Information

  • Prescription Required: Wegovy must be prescribed and monitored by a healthcare professional.

  • Follow Dosage Instructions: Do not exceed the recommended dose and adhere to your dosing schedule.

  • Monitoring: Regular checks of weight, blood sugar, and other health indicators are recommended during treatment.

  • Side Effects: Common side effects include nausea, vomiting, and diarrhoea, especially during dose escalation. Speak to your doctor if side effects persist.

Key Takeaway

Wegovy tablets provide a convenient, clinically proven weight loss solution for adults struggling with obesity or overweight conditions.

With its daily dosing, appetite control benefits, and long-term health improvements, Wegovy offers a safe and effective option when combined with lifestyle changes and medical supervision.

Directions

How to Use Wegovy (Semaglutide)

  • Frequency: Swallow one pill daily with half a cup of water. Wait at least 30 minutes before eating or drinking anything else
  • Dosing Schedule: Follow the dose escalation plan exactly as prescribed by your healthcare provider.

Storage Instructions

  • Storage: Store at room temperature
  • Protection: Keep pills in their original carton to protect from light.
  • Safety: Store out of reach of children at all times.

Ingredients

Active Ingredient:

  • Semaglutide – the GLP-1 receptor agonist responsible for appetite regulation, improved satiety, and weight management support.

Other Ingredients (Excipients):

  • Disodium phosphate dihydrate
  • Sodium chloride
  • Hydrochloric acid or sodium hydroxide (used for pH adjustment)
  • Water for injection

Side Effects

Like all prescription medications, Wegovy can cause side effects. These may range from mild and temporary to rare but serious. Always follow your doctor’s advice and report any unusual symptoms.

Common Side Effects

These are the most frequently reported and often improve as your body adjusts:

  • Nausea
  • Diarrhoea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Headache
  • Fatigue (tiredness or low energy)

Uncommon Side Effects

These occur less often but may still affect some patients:

  • Dizziness
  • Indigestion (dyspepsia)
  • Flatulence (gas)
  • Gastroesophageal reflux disease (acid reflux/heartburn)

Serious (Rare) Side Effects

Though uncommon, these require immediate medical attention:

  • Pancreatitis (severe abdominal pain, possibly radiating to the back, often with nausea or vomiting)
  • Gallbladder problems (pain in the upper right abdomen, fever, jaundice)
  • Kidney problems (changes in urination, swelling in legs/ankles, fatigue)
  • Severe allergic reactions (anaphylaxis)

Call emergency services immediately if you notice:

  • Swelling of the face, lips, tongue, or throat
  • Difficulty breathing or swallowing
  • Severe rash or hives

Warnings

Do not use Wegovy if you:

  • Are allergic to semaglutide or any of its ingredients.
  • Have a personal or family history of medullary thyroid carcinoma (MTC).
  • Have been diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Use With Caution If You:

  • Have a history of pancreatitis.
  • Have kidney or liver problems.
  • Are pregnant or planning a pregnancy.
  • Are breastfeeding.

Always discuss your full medical history with your healthcare provider before starting treatment.

Age Restrictions

  • Wegovy is not recommended for individuals under 18 years of age.
  • Safety and effectiveness in children and adolescents have not yet been established.

Important: Only take Wegovy if it has been prescribed and approved by a healthcare professional. Regular monitoring is essential to ensure the treatment is safe and effective for your individual needs.

  • Wegovy is a prescription-only weight loss medication that contains semaglutide, a medication that mimics a natural hormone in the body. It helps reduce appetite, increase feelings of fullness, and regulate hunger, making it easier to follow a calorie-controlled diet and achieve long-term weight loss.
  • Many people begin to notice reduced appetite and changes in eating habits within the first few weeks of starting Wegovy. Significant weight loss results are usually seen over a period of several months, especially when combined with a healthy diet and lifestyle changes.
  • Yes. With Onlinemeds, you can order Wegovy online by completing a short health consultation. A licensed prescriber will review your answers and, if suitable, your medication will be dispensed and delivered discreetly to your home — without the long waiting times of a GP appointment.
  • The Wegovy pill is licensed for use in adults who have:

    • A body mass index (BMI) of 30 or above (classified as obesity)
    • A BMI of 27 or above with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or raised cholesterol

    Eligibility is similar to the Wegovy injection.

    However, the oral formulation may be a clinically appropriate option for those who are unable or unwilling to self-administer injections, or who prefer a daily tablet to a once-weekly injection.

    It is not automatically a suitable alternative for everyone currently using the injection, and an individual clinical assessment is required.

    The Wegovy pill is not recommended for people with a personal or family history of medullary thyroid carcinoma, those with Multiple Endocrine Neoplasia syndrome type 2 (MEN2), or those who are pregnant or breastfeeding.

  • Switching from Wegovy injections to the Wegovy pill is possible, though any change to your treatment should be discussed with your prescriber before you stop or alter your current dose.

    Clinical guidance indicates that adults who are currently stable on the 2.4 mg weekly Wegovy injection may be able to transition directly to the 25 mg oral tablet - the highest maintenance dose of the pill.

    This is based on equivalence data reviewed as part of the MHRA approval process for the Wegovy pill.

    Whether switching is appropriate for you will depend on a number of individual factors, including how well your current treatment is working, any side effects you have experienced, and your overall health profile. Your prescriber will assess your suitability before making any changes.

  • The Wegovy pill is available in four strengths: 1.5 mg, 4 mg, 9 mg, and 25 mg.

    Treatment begins at the lowest dose and is increased gradually over time to help the body adjust and to minimise the risk of gastrointestinal side effects such as nausea.

    The standard titration schedule is as follows:

    • Month 1: 1.5 mg once daily
    • Month 2: 4 mg once daily
    • Month 3: 9 mg once daily
    • Month 4 onwards: 25 mg once daily (maintenance dose)

    Your prescriber may recommend staying at a lower dose for longer if side effects are difficult to manage, or if a slower titration is considered more appropriate for you.

    The tablet must be taken on an empty stomach, after fasting for at least eight hours, with no more than ha;f a glass of plain water.

    You should avoid eating or drinking anything other than water for at least 30 minutes after taking the tablet, as food and drink can significantly reduce absorption. The tablet should be swallowed whole and not chewed, crushed, or split.